Monte Rosa Therapeutics (GLUE) EPS (Basic) (2020 - 2026)
Monte Rosa Therapeutics' (GLUE) quarterly EPS (Basic) came in at -$0.45 in Q1 2026, down 178.15% year-on-year from $0.57 in Q1 2025, and down 25.65% quarter-over-quarter from -$0.35 in Q4 2025.
Monte Rosa Therapeutics (GLUE) EPS (Basic) (2020 - 2026) Analysis & Trends
Monte Rosa Therapeutics' EPS (Basic) history runs 7 years deep, the most recent figure standing at -$0.45 for Q1 2026.
- On a quarterly basis, EPS (Basic) fell 178.15% year-over-year to -$0.45 in Q1 2026; TTM through Mar 2026 was -$1.14, a 497.77% decrease from a year earlier, with the FY2025 full-year figure at -$0.26, up 64.7% from the prior year.
- EPS (Basic) fell to -$0.45 in Q1 2026 per GLUE's latest filing, from -$0.35 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.57 in Q1 2025 and bottomed at -$1.39 in Q1 2022.
- The 5-year median for EPS (Basic) is -$0.53 (2024), against an average of -$0.44.
- Biggest YoY gain for EPS (Basic) was 207.34% in 2025; the steepest drop was 185.37% in 2025.
- Year by year, EPS (Basic) stood at -$0.65 in 2022, then increased by 0.74% to -$0.65 in 2023, then soared by 164.27% to $0.42 in 2024, then slumped by 185.37% to -$0.35 in 2025, then dropped by 25.65% to -$0.45 in 2026.
- Per Business Quant, the three latest GLUE EPS (Basic) figures stand at -$0.45 (Q1 2026), -$0.35 (Q4 2025), and -$0.33 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Monte Rosa Therapeutics | 2.30 Bn | 1.62 Bn | - | -0.45 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.45 |
| Dec 31, 2025 | -0.35 |
| Sep 30, 2025 | -0.33 |
| Jun 30, 2025 | -0.15 |
| Mar 31, 2025 | 0.57 |
| Dec 31, 2024 | 0.42 |
| Sep 30, 2024 | -0.29 |
| Jun 30, 2024 | -0.43 |
| Mar 31, 2024 | -0.53 |
| Dec 31, 2023 | -0.65 |
| Sep 30, 2023 | -0.70 |
| Jun 30, 2023 | -0.71 |
| Mar 31, 2023 | -0.65 |
| Dec 31, 2022 | -0.65 |
| Sep 30, 2022 | -0.58 |
| Jun 30, 2022 | -0.57 |
| Mar 31, 2022 | -1.39 |
| Dec 31, 2021 | -1.65 |
| Sep 30, 2021 | -2.22 |
| Jun 30, 2021 | -20.27 |